Dynamic Technology Lab Private Ltd increased its stake in shares of MedEquities Realty Trust Inc. (NYSE:MRT) by 25.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 16,686 shares of the financial services provider’s stock after buying an additional 3,346 shares during the period. Dynamic Technology Lab Private Ltd owned 0.05% of MedEquities Realty Trust worth $210,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. UBS Group AG boosted its holdings in shares of MedEquities Realty Trust by 190.0% during the 1st quarter. UBS Group AG now owns 13,504 shares of the financial services provider’s stock worth $151,000 after buying an additional 8,847 shares during the period. Eqis Capital Management Inc. bought a new stake in shares of MedEquities Realty Trust during the 2nd quarter worth about $153,000. Raymond James Financial Services Advisors Inc. bought a new stake in shares of MedEquities Realty Trust during the 2nd quarter worth about $154,000. Acadian Asset Management LLC bought a new stake in shares of MedEquities Realty Trust during the 2nd quarter worth about $175,000. Finally, Alliancebernstein L.P. bought a new stake in shares of MedEquities Realty Trust during the 2nd quarter worth about $175,000. 93.05% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “MedEquities Realty Trust Inc. (MRT) Shares Bought by Dynamic Technology Lab Private Ltd” was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://theolympiareport.com/2017/11/02/medequities-realty-trust-inc-mrt-shares-bought-by-dynamic-technology-lab-private-ltd.html.

MRT has been the subject of several research analyst reports. Cantor Fitzgerald initiated coverage on shares of MedEquities Realty Trust in a report on Thursday, August 31st. They set an “overweight” rating and a $14.00 target price for the company. KeyCorp reaffirmed a “buy” rating and set a $13.00 target price on shares of MedEquities Realty Trust in a report on Friday, August 25th. Zacks Investment Research raised shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. Finally, Capital One Financial Corporation reaffirmed an “equal weight” rating on shares of MedEquities Realty Trust in a report on Sunday, October 22nd. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $13.00.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Institutional Ownership by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.